Prevail Therapeutics Inc. (PRVL) has 3 open-market insider trades by 3 insiders since 2019. The most active filer is Tyto Acquisition Corp, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Tyto Acquisition Corp | 10% Owner | — | 1 | $1.5B | 2021-01-22 |
| Carl L. Gordon | Dir10% Owner | — | 1 | $15.0M | 2021-01-22 |
| Peter A. Thompson | Dir10% Owner | — | 1 | $15.0M | 2021-01-22 |
| Orbimed Advisors LLC | Dir10% Owner | — | 0 | — | 2019-06-24 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Tyto Acquisition Corp | 10% Owner | Buy | $1.5B | 2021-01-22 |
| Carl L. Gordon | Director & 10% Owner | Buy | $15.0M | 2019-06-24 |
Companies that share insiders with PRVL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.